Associate Professor Ling Yang
Research groups
- Assessing the roles of chronic infections, host immunity, and chronic inflammation in disease aetiology
- Assessment of the role of EBV infection in aetiology of nasopharyngeal and gastric cancers in Chinese adults CRUK STUDENTSHIP AVAILABLE
- Chronic infection, host immunity and risk of cancer (MRC PHRU)
- Chronic infection, host immunity, and non-communicable disease risk
- Chronic infection, host immunity, and disease risk
- Female reproductive history and risks of cancer and other diseases in a prospective cohort study of 300,000 Chinese women
- Genomic analysis of reproductive health in Chinese populations
- Reproductive factors and breast cancer risk in diverse populations
Ling Yang
PhD
Senior Epidemiologist
Ling is a senior epidemiologist at The Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) and the Medical Research Council Population Health Research Unit at the University of Oxford (MRC PHRU), and leads the long-term follow-up working group, women health and infection and cancer research groups in the China Kadoorie Biobank study (CKB).
Her main research focus are on women’s reproductive health, chronic infection and environmental causes of chronic diseases (especially cancer) based on large scale cohort studies, and evidence-based medicine using large national disease surveillance and risk factors survey data to provide strategies for chronic disease prevention and control in developing countries.
Before moving to the University of Oxford in 2007, Ling worked at the Chinese Academy of Medical Science (CAMS) and Ministry of Health in Beijing (China), WHO International Agency for Research on Cancer in Lyon (IARC/WHO, France) and Karolinska Institutet in Stockholm (Sweden).
Ling qualified in Medicine at South-Eastern University (China) in 1995 then gained her MSc in Bio-statistics in 1998 there, and her PhD in Epidemiology at the University of Tampere (Finland) in 2005.
Recent publications
-
Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensive Adults.
Journal article
Sun Z. et al, (2024), Hypertension, 81, 2529 - 2539
-
Predictive value of 8-year blood pressure measures in intracerebral haemorrhage risk over 5 years.
Journal article
Zhang Y. et al, (2024), Eur J Prev Cardiol, 31, 1702 - 1710
-
DNA Methylation Age Mediates Effect of Metabolic Profile on Cardiovascular and General Aging.
Journal article
Si J. et al, (2024), Circ Res
-
One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study.
Journal article
Sun Z. et al, (2024), Lancet Reg Health West Pac, 49
-
Causal relevance of different blood pressure traits on risk of cardiovascular diseases: GWAS and Mendelian randomisation in 100,000 Chinese adults.
Journal article
Pozarickij A. et al, (2024), Nat Commun, 15